Boehringer Ingelheim's New Quarterable Snap-Tab PREVICOX® (firocoxib) Chewable Tablets Provide Flexible Dosing for Dogs in the U.S.

RegulatoryapprovedPREVICOXPositive

AI Analysis

Summary

Boehringer Ingelheim received FDA approval for a new quarterable snap-tab chewable tablet formulation of PREVICOX (firocoxib) for dogs, enabling more precise customizable dosing based on weight with improved convenience and sustainability benefits.

Outcome Details

FDA approved new quarterable snap-tab chewable tablet formulation with flexible dosing design

Importance:4/10

Sentiment:

0.70

FDA approvalveterinaryproduct reformulationdosing flexibility

Read the original article

Published by PR Newswire Biotech on October 7, 2026 7:00 PM

Read Original